Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia

Crit Care Med. 1990 Dec;18(12):1374-7. doi: 10.1097/00003246-199012000-00013.

Abstract

The effects of iv salbutamol on respiratory mechanics were studied in six infants with bronchopulmonary dysplasia. Salbutamol was infused at a dose of 30 micrograms/kg over 30 min in five infants; a sixth infant received 66.7 micrograms/kg over 4 min. Salbutamol caused improvement in total respiratory system compliance and in airflow resistance. There was no correlation between salbutamol serum concentration and pulmonary function. Elimination half-time appears to be dictated in these infants more by the distribution volume (Vd) than by clearance (Cl). The area under concentration-time curve of salbutamol correlated inversely to the change in heart rate (HR). There was a significant positive correlation between Vd and percent HR change. These data provide evidence that preterm infants have measurable activity of bronchiolar beta 2 receptor responsive to salbutamol.

Publication types

  • Clinical Trial

MeSH terms

  • Airway Resistance / drug effects
  • Albuterol / pharmacokinetics
  • Albuterol / pharmacology*
  • Albuterol / therapeutic use
  • Biomechanical Phenomena
  • Bronchopulmonary Dysplasia / drug therapy*
  • Bronchopulmonary Dysplasia / physiopathology
  • Hemodynamics / drug effects
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Lung Compliance / drug effects
  • Receptors, Adrenergic, beta / analysis
  • Respiration / drug effects*

Substances

  • Receptors, Adrenergic, beta
  • Albuterol